Cogent Biosciences, Inc. · NASDAQ:COGT
BlackRock, Inc. reported a 6.50% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 6.50% stake in Cogent Biosciences, Inc., 11,370,224 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 11,370,224
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.50% | 11,370,224 |
Source
Related
- Cogent Biosciences, Inc.
- BlackRock, Inc.
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Robbins Andrew R · May 21, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026